IMMX
NASD Immix Biopharma, Inc.$9.68 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.68, $0.69 below the day’s high of $10.37
- YTD change
- +85.09%
- vs 20-day SMA
- -20.05%
- vs 200-day SMA
- +6.03%
Price ranges
Price & Performance
+1.09 (+12.69%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 35.9% away from all-time highs of $15.10
- IMMX is up 85% since the beginning of the year
- IMMX is up 361% over the past 12 months
- IMMX is down 31% over the past 1 month
- 13% of all IMMX investors are betting against IMMX
IMMX reads poor: price sits above one of the two key moving averages, the 12-month move is +331.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.09
- Last 5 days
- -17.26%
- vs 8-day SMA
- -14.02%
No alerts for IMMX in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.